Everything we do, every company we build, every product we make, every service we provide, helps dental professionals achieve their goals. And it’s this clear focus that fuels our businesses, our people, and our success.
This is our vision as we continue to transform the dental industry, responding to key growth drivers including digitization, increased focus on dentistry as a business, and expanding opportunities in emerging markets worldwide. By responding to these trends and to the needs of our professional partners as they build their practices and care for their patients, we strengthen our ability to champion creators of confidence.
Everything starts and ends with people – our customers, their patients, our colleagues, communities, and shareholders. People make all progress possible.
Paul Keel, CEO and Envista's Chairman of the Board, leads Envista in living our mission of digitizing, personalizing, and democratizing dental care.
Before Envista, Paul was CEO of Smiths Group plc, a FTSE 100 global technology company, where he led the organization to record growth and profitability. Prior to Smiths, he spent nearly two decades with 3M in various leadership roles including Group President of the Consumer Business, SVP Marketing & Sales, SVP Manufacturing & Supply Chain, President of 3M Medical, and President of 3M’s Specialty Dental business. Preceding 3M, he held positions of increasing responsibility at GE, McKinsey, and General Mills.
Paul holds a BA from Carleton College and an MBA from Harvard Business School.
I believe a few basic leadership principles are critical for success in career and life. Stay focused on winning with your customers. Know your strengths, while humbly acknowledging your weaknesses. Aspire to win, with a meaningful purpose. Empower people. Be strong in your faith.
As Envista's Chief Financial Officer, Eric Hammes leads the global, corporate financial function for the organization.
Eric joins Envista from Rockwell Automation, where he served as Vice President, Corporate Financial Planning and Analysis. Prior to Rockwell, Eric spent over 25 years at 3M where he held a variety of senior financial leadership roles including SVP Controller and Chief Accounting Officer, CFO of 3M Health Care Business Group, Director Finance of 3M Orthodontic Products Division, and SVP of International Finance. In addition to his deep finance and accounting experience, Eric has held several senior operating roles including EVP of Business Transformation & IT, EVP Chief Country Governance and Services Officer, and EVP of Enterprise Operations, a role that spanned 170 manufacturing sites and over $30 billion in annual production. Eric has previously lived and worked in the US, Europe, and Asia. He received a Bachelor of Science degree in Finance from the University of Minnesota.
There is so much unmet patient need for dentistry across the globe. What an honor it is to leverage the latest in data and technology to improve patient health and smiles worldwide!
As Envista’s CIO, Andrew Chen oversees the use of data and technology to enable and protect our mission to digitize, personalize, and democratize dental care globally.
Andrew joined Envista from Kite Pharma, an industry leading cell therapy biotech, where he was most recently Chief Information Officer. Prior to Kite, Andrew held senior Information Technology leadership positions in firms across multiple industries, including Seattle Genetics, AstraZeneca, JP Morgan Chase, DuPont, Bank of America, and W. L. Gore & Associates. Andrew brings over 30 years experience in IT, with the last 18 years in the healthcare industry, spanning Asia, Europe, LATAM and US.
Andrew holds a B.S. in Electrical Engineering from the University of Delaware and an Executive Master’s in Technology Management from the Wharton School and Penn Engineering at the University of Pennsylvania.
As Envista’s CHRO, Suraj maintains responsibility for talent processes and people strategy. Suraj joins Envista from Cepheid, a global diagnostics company under Danaher, where he most recently served as SVP, Human Resources & Internal Communications. Suraj joined Cepheid during the COVID-19 pandemic and was instrumental in supporting the company’s growth from $1B to $3B in revenue and from 3,000 to 6,000 associates globally. During this period of hypergrowth, Suraj was actively involved in building the HR infrastructure while strengthening the capabilities and disciplines amongst the leadership team and more broadly throughout the organization. Specifically, Suraj drove transformation through various aspects of Cepheid’s culture, DE&I, HR excellence, commercial execution, and innovation.
Prior to Cepheid, Suraj spent nearly 14 years at Gilead Sciences where he held various HR leadership roles, including an international assignment based in the UK as Vice President, HR EMEA. During the company’s rapid growth from $5B to over $32B, Suraj successfully utilized his strong data-driven and program management skills to simplify, integrate, and scale talent processes and develop a more agile, operationally excellent HR function. His experience at Gilead also included navigating complex business cycles and M&A integrations globally.
Suraj holds a Bachelor of Arts in Molecular & Cell Biology from the University of California, Berkeley. Suraj and his wife Kelley, who is a pediatric dentist, and their daughters reside in Newport Beach, California.
My 'Why' is to improve ethics, fairness, and compassion in the world through enterprise leadership. I wish to leave this as a legacy to my children, future business leaders, and my community.
As President Orthodontics at Envista, Veronica leads the Ormco business, committed to providing best-in-class orthodontic treatment options and service to customers.
Most recently, Veronica served as President of 3M’s $5 billion Medical Solutions Division. Prior to that, she held various commercial, operational, and business leadership roles around the world including SVP of 3M Health Care in the Greater China region, Managing Director of 3M Taiwan, VP Business Development of 3M Health Care for Latin America, and Global Business Director of 3M Oral Care Division’s Restorative business.
Veronica has lived and worked in the US, Asia, and Latin America and holds a Business Administration degree from the Universidad del Pacifico in Lima, Peru.
As President of Imaging and Diagnostics, Robert oversees Envista’s intraoral scanning, imaging, and DTX businesses to deliver diagnostic confidence, productivity, and smart simplicity to the dental community.
Robert joins Envista from 3M, where he most recently was President of the Separation and Purification Sciences Division, a global filtration technology leader. Prior to that, he led the global go-to-market transformation for the 3M Medical Solution Division, the largest division at 3M at the time. He also held several senior executive roles in the 3M Health Care Business Group, including leading Global Marketing, Strategy, M&A, and Data Security & Compliance.
Prior to 3M, Robert worked in private equity, consulting, and investment banking research at Piper Sandler Companies (NYSE: PIPR). He co-founded Gordian Capital, a private equity company where he led capital raising, deal origination, industry research, transaction structuring, and portfolio management. While at Gordian, he served as Chief Executive Officer of a portfolio company specializing in providing HR business outsourcing services.
He holds an MBA with Honors from the Wharton School at the University of Pennsylvania, an M.S. in Software Engineering from the University of Minnesota, and a B.S. in Computer Science, summa cum laude, from Winona State University.
There’s never been a more exciting time to be in dentistry. I am motivated by Envista’s customer centric approach to innovation and transformation, helping to empower dental professionals and help elevate the quality of dental care provided across the world.
Filippo Impieri is President, Consumables, overseeing the Kerr, Metrex and Orascoptic businesses.
Previously, as SVP of Emerging Markets, Filippo Impieri led Envista’s commercial organization dedicated to high growth markets across APAC, LATAM, Eastern Europe, and MEA&T.
Filippo joined Danaher in 2004 as the result of the company's first acquisition in the dental industry. He has held several roles including VP/GM Commercial, managing the sales and service imaging team in North America, and more recently, SVP Special Markets, leading the central DSO and Marketing organizations. Before joining Danaher, Filippo worked in marketing and product management in the Gendex division of Dentsply Italy.
Filippo holds an MS in Electrical Engineering from the Politecnico of Milan and an MBA from the University of Chicago Booth School of Business. He lives in Los Angeles, California with his husband and two dogs.
Jay Issa is a seasoned global business leader with more than 25 years of experience driving growth, transformation, and innovation across the healthcare, dental, and orthodontic industries. He brings deep expertise in portfolio strategy, business development, digital health solutions, and multichannel product distribution across diverse global markets. Jay is known for delivering strong financial results, leading high‑performing cross‑functional teams, and navigating complex business challenges. He is multilingual and deeply committed to strategic execution, operational excellence, and inclusive leadership.
Envista’s core values, which we refer to as CIRCLe, and our dedication to EBS principles provide a foundation for growth and notable quality in an environment where our team is proud to come to work each day.
Mark joined Envista in 2019 prior to its IPO. Previously he served as Chief Legal Officer for INSYS Therapeutics, Inc., where he teamed with management and the board to focus on its restructuring. He has nearly 20 years of experience serving in the role of General Counsel.
Mark has also held roles as General Counsel for Mylan, N.V., a global pharmaceutical company, and led the legal teams at G.E. Healthcare Medical Diagnostics and G.E. Healthcare Life Sciences. His government service includes time at the Office of Policy Planning at the U.S. Federal Trade Commission, as a commissioned officer in the U.S. Marine Corps, and for seven years as an original member of the National Science Advisory Board for Biosecurity.
Mark holds a BA in Political Science from the University of Missouri and a JD from Cornell Law School.
As President of Nobel Biocare, Stefan Nilsson leads Envista’s premium implant brand, known in the industry for being first to market with unmatched quality, excellent training, and commitment to an esteemed community of customers.
Stefan joins Envista from Colosseum Dental Group, which grew to be one of Europe’s largest Dental Service Organizations under his leadership. Stefan’s unwavering commitment to superior clinical outcomes and patient experience enabled Colosseum to more than double revenues in the five years while he was CEO. He is a passionate advocate for digitizing clinical workflows and will further accelerate our own progress in this regard.
Prior to Colosseum, Mr. Nilsson was CEO of GrandVision Brazil, a leading eyecare service provider. Further, he had a distinguished career at Nestle in a variety of operations, marketing, and general management roles around the world. After serving in the Swedish military, Stefan received a Master of Science degree from the Royal Institute of Technology in Sweden and an MBA from Rochester University in New York.
Stefan is based in Zurich, Switzerland.
Outstanding products are a clear differentiator in the dental market, and Envista’s Quality function is focused on delivering them. We continually improve our design and manufacturing processes using EBS to ensure our customers have the best possible products on time.
As SVP of Regulatory Affairs and Quality Assurance, Claudia Ortiz leads Envista’s regulatory affairs, quality, and compliance functions.
Claudia originally joined Danaher in 2003 as Quality Engineer for KaVo Kerr. She held various progressive roles within Quality and Regulatory Affairs and was appointed VP of Regulatory Affairs and Compliance for Danaher in 2012.
Claudia holds a BS in Chemical Engineering from the University of Stuttgart, Germany. She lives in Aliso Viejo, California, with her husband and two children and enjoys being involved in their sports activities.
Our team’s focus is on driving top- and bottom-line growth for Envista by developing strategies that create sustainable competitive advantage and deploying our capital into strategically and financially accretive acquisitions.
As SVP Strategy & Corporate Development, Mischa Reis leads Envista’s strategic planning and mergers and acquisitions (M&A) activities, including portfolio management, market analysis, deal sourcing, valuation, due diligence, negotiation, and deal execution.
Mischa joined Danaher in 2012 as VP Business Development and Strategy for the Dental Platform, with responsibility for driving its strategy and inorganic growth activities. During his tenure, he completed more than 10 deals spanning four continents, ranging from small minority investments in innovative startups to the $2B+ acquisition of Nobel Biocare.
Prior to Danaher, Mischa worked at Fortune 500 company Avery Dennison for 10 years in a variety of business development, marketing, and strategy roles, most recently as VP and Head of Corporate Strategy. He started his career as a consultant at The Boston Consulting Group in Frankfurt, Germany.
Mischa holds a master’s degree equivalent in Business Administration & Industrial Engineering from the Karlsruhe Institute of Technology, Germany. He lives in Los Angeles, California, with his wife and three kids and is a passionate soccer player (and even more passionate soccer fan of his hometown team, Bayern Munich).
Scott Huennekens served as Envista's Chairman of the Board from 2019 to 2026. He is the former Chairman, President, and CEO of Verb Surgical, Inc., an independent surgical technology company formed in 2015 by Google and Johnson & Johnson. He serves as a Board member at QuidelOrtho (QDEL), a leading point of care diagnostics company and as a Board member at NeuroPace, Inc. (NPCE), a medical device company focused on transforming the lives of people living with epilepsy.
Prior to his tenure at Verb Surgical, Inc., Scott was President and CEO of Volcano Corporation for 13 years and President and CEO of Digirad Corporation. He also held various positions at Baxter Healthcare, Birtcher Medical Systems, and Deloitte and Touche. Scott has more than 25 years of experience in the medical device industry.
Scott received a BS in Business Administration from the University of Southern California and an MBA from the Harvard Business School.
Wendy Carruthers is the former Executive Vice President and Chief Human Resources Officer for Boston Scientific, a medical device company dedicated to transforming lives through innovative medical solutions. She held the role of CHRO for 12 years and prior roles with Boston Scientific include VP Global Talent and HR VP, Europe, Middle East and Africa. She held a variety of HR leadership roles with Cable & Wireless, Diageo plc and Tesco plc prior to joining Boston Scientific. Wendy has lived and worked in U.K., Italy, France, Australia and U.S.A
Wendy currently serves as a Board member for Vantive, a vital organ therapy company.
Wendy holds a B.A. First Class Honors Degree in Modern Languages from the University of Salford, U.K. and is a Fellow of the Chartered Institute of Personnel and Development.
Paul Keel, CEO and Envista's Chairman of the Board, leads Envista operationally in living our mission of digitizing, personalizing, and democratizing dental care.
Before Envista, Paul was CEO of Smiths Group plc, a FTSE 100 global technology company, where he led the organization to record growth and profitability. Prior to Smiths, he spent nearly two decades with 3M in various leadership roles including Group President of the Consumer Business, SVP Marketing & Sales, SVP Manufacturing & Supply Chain, President of 3M Medical, and President of 3M’s Specialty Dental business. Preceding 3M, he held positions of increasing responsibility at GE, McKinsey, and General Mills.
Paul holds a BA from Carleton College and an MBA from Harvard Business School.
Vivek Jain has served as CEO and Chairman of the Board of ICU Medical, Inc., a global medical technology company specializing in infusion therapy, since February 2014. Prior to this role, Mr. Jain served at CareFusion Corporation, a global medical technology company, as President of Procedural Solutions from 2011 to February 2014 and as President, Medical Technologies and Services from September 2009 until 2011. Before joining CareFusion Corporation, Mr. Jain was EVP of Strategy and Corporate Development of Cardinal Health, Inc., a health care services company, from June 2007 until August 2009.
Vivek served as an investment banker at J.P. Morgan Securities, Inc., an investment banking firm, from 1994 to 2006. Vivek received a BA in economics from the University of Chicago
Daniel Raskas is the former SVP, Corporate Development of Danaher, co-leading mergers and acquisitions (M&A). He oversaw investment activity, including identification, valuation, due diligence, contract strategy, and negotiations.
Daniel joined Danaher in 2004, originally serving as VP, Corporate Development, and was promoted to his SVP role in 2010. Throughout his tenure, he led business development across the company and oversaw a number of major acquisitions, including Beckman Coulter and Pall.
Before joining Danaher, Daniel was a partner at Thayer Capital Partners, a private equity firm focused on buyout and growth equity investments in the middle market. He also served as an associate at Arnold & Porter LLP for several years, where he specialized in transactional work including M&A and public offerings.
Daniel received a BA in Government from Harvard College, an MBA from Columbia University School of International and Public Affairs, and a JD from Harvard Law School.
Kieran T. Gallahue is the former Chairman and Chief Executive Officer of CareFusion Corporation, a global medical technology company, from 2011 until its acquisition by Becton, Dickinson and Company in March 2015. From January 2008 through January 2011, Mr. Gallahue served as President, Chief Executive Officer and a Director of ResMed, Inc., a medical device firm serving the sleep-disordered breathing and respiratory markets. Mr. Gallahue is currently a member of the Board of Directors of Edwards Lifesciences Corp.
Prior to his time at ResMed, Inc., Mr. Gallahue held various marketing, sales and financial positions within Nanogen, Inc., Instrumentation Laboratory, the Procter & Gamble Company, and the General Electric Company. Mr. Gallahue also served on the Executive Committee of the Advanced Medical Technology Association, a trade association representing 80% of medical technology firms in the United States.
Mr. Gallahue holds a bachelor’s degree in Economics from Rutgers University and an MBA from Harvard Business School.
Christine Tsingos is the former EVP and CFO at Bio-Rad, a company focused on life science research and clinical diagnostic systems. She serves on the boards of Varex Imaging, an X-ray component manufacturer, and Nanometrics, which produces metrology and inspection systems for a variety of industries.
Prior to her 17 years at Bio-Rad, Christine held various positions at Attest Systems, Tavolo, Autodesk, and The Cooper Companies.
Christine received a BA in International Studies from American University and an MBA in International Business from George Washington University.
Andy Pierce has served as Group President, MedSurg & Neurotechnology, of Stryker Corporation, a global medical technology company, since August 2019. Mr. Pierce joined Stryker in 1996, serving in various leadership roles including President of Stryker’s Endoscopy division, Vice President and General Manager of Stryker’s Surgical and Neuro Spine ENT business units, and Vice President and General Manager of Stryker’s Craniomaxillofacial business.
Creating confidence is no small business. With deep industry roots and decades of world-class experience, the people behind Envista know this well. Our companies help dental professionals deliver the best possible patient care through industry-leading products, solutions, and technology.
